Global Retirement Partners LLC Has $475,000 Stake in Omega Healthcare Investors, Inc. (NYSE:OHI)

Global Retirement Partners LLC trimmed its position in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 29.0% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 11,673 shares of the real estate investment trust’s stock after selling 4,760 shares during the period. Global Retirement Partners LLC’s holdings in Omega Healthcare Investors were worth $475,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the stock. Fisher Asset Management LLC bought a new position in Omega Healthcare Investors in the 4th quarter valued at approximately $206,000. Park Avenue Securities LLC grew its position in Omega Healthcare Investors by 5.7% in the 1st quarter. Park Avenue Securities LLC now owns 10,066 shares of the real estate investment trust’s stock valued at $319,000 after purchasing an additional 544 shares during the period. Community Bank of Raymore boosted its holdings in Omega Healthcare Investors by 23.2% during the 1st quarter. Community Bank of Raymore now owns 16,555 shares of the real estate investment trust’s stock worth $524,000 after acquiring an additional 3,115 shares during the last quarter. Future Financial Wealth Managment LLC boosted its holdings in Omega Healthcare Investors by 5.0% during the 1st quarter. Future Financial Wealth Managment LLC now owns 8,403 shares of the real estate investment trust’s stock worth $266,000 after acquiring an additional 400 shares during the last quarter. Finally, Sovereign Financial Group Inc. purchased a new position in Omega Healthcare Investors during the 1st quarter worth $309,000. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Omega Healthcare Investors Stock Down 0.7 %

NYSE OHI opened at $41.32 on Tuesday. The stock’s 50-day moving average price is $39.78 and its 200-day moving average price is $35.36. The company has a quick ratio of 5.79, a current ratio of 5.79 and a debt-to-equity ratio of 1.19. Omega Healthcare Investors, Inc. has a 52 week low of $27.53 and a 52 week high of $41.73. The company has a market capitalization of $10.21 billion, a P/E ratio of 37.23, a price-to-earnings-growth ratio of 1.29 and a beta of 1.00.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings data on Thursday, August 1st. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.65 by ($0.20). Omega Healthcare Investors had a return on equity of 8.61% and a net margin of 33.52%. The firm had revenue of $252.70 million during the quarter, compared to the consensus estimate of $205.92 million. During the same period in the previous year, the firm earned $0.74 EPS. The business’s revenue was up 17.5% compared to the same quarter last year. On average, equities research analysts predict that Omega Healthcare Investors, Inc. will post 2.69 earnings per share for the current year.

Omega Healthcare Investors Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Thursday, August 15th. Stockholders of record on Monday, August 5th were issued a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.49%. The ex-dividend date of this dividend was Monday, August 5th. Omega Healthcare Investors’s dividend payout ratio (DPR) is 241.44%.

Wall Street Analyst Weigh In

OHI has been the topic of a number of recent analyst reports. Berenberg Bank initiated coverage on Omega Healthcare Investors in a research note on Friday. They set a “buy” rating and a $45.00 target price on the stock. Wells Fargo & Company restated an “overweight” rating and issued a $43.00 price objective (up from $40.00) on shares of Omega Healthcare Investors in a research note on Tuesday, October 1st. Scotiabank upped their price target on Omega Healthcare Investors from $33.00 to $39.00 and gave the company a “sector perform” rating in a research report on Monday, August 26th. Truist Financial boosted their price objective on Omega Healthcare Investors from $33.00 to $39.00 and gave the stock a “hold” rating in a report on Wednesday, September 4th. Finally, Mizuho lowered Omega Healthcare Investors from an “outperform” rating to a “neutral” rating and upped their target price for the stock from $34.00 to $35.00 in a research note on Thursday, July 25th. Eight analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $37.80.

Insider Transactions at Omega Healthcare Investors

In other Omega Healthcare Investors news, CFO Robert O. Stephenson sold 22,542 shares of the company’s stock in a transaction on Friday, September 27th. The stock was sold at an average price of $40.19, for a total value of $905,962.98. Following the transaction, the chief financial officer now owns 183,076 shares of the company’s stock, valued at $7,357,824.44. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other Omega Healthcare Investors news, COO Daniel J. Booth sold 56,725 shares of the stock in a transaction dated Friday, September 27th. The stock was sold at an average price of $40.25, for a total value of $2,283,181.25. Following the completion of the sale, the chief operating officer now directly owns 100,000 shares in the company, valued at approximately $4,025,000. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CFO Robert O. Stephenson sold 22,542 shares of the stock in a transaction dated Friday, September 27th. The shares were sold at an average price of $40.19, for a total value of $905,962.98. Following the completion of the sale, the chief financial officer now owns 183,076 shares of the company’s stock, valued at approximately $7,357,824.44. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.37% of the company’s stock.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.